Atlas Trials

Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

Clinical trial NCT02981082 · TERMINATED

Trial details

NCT number
NCT02981082
Sponsor
Robert Lafyatis
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Systemic SclerosisPulmonary; Hypertension
Start date
2016-12-01
Primary completion
2020-02-10
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.